Axa’s US IPO prices well below expectations

The sale of one of Axa’s US businesses, which will be used to fund the French insurance giant’s purchase of XL Group, is likely to bring in far less than it initially expected.

 

Want to read this article?

 

For details on how to subscribe or for all commercial opportunities, including advertising, please contact:

Andy Stone

Sales manager

+44 (0) 77 4160 9204

andy.stone@wbmediagroup.com

    Ricky Lamey

    Business development executive

    ricky.lamey@thomsonreuters.com